Pharma News India

The Hyderabad based company is aiming to achieve US$ 2 billion revenue.

Hyderabad, August 5, 2014: Aurobindo Pharma aims to achieve US$ 2 billion turnover in the current financial year. The company is also looking at securing nine more injectables approvals from USFDA.

Indoco Remedies has received the approval for its two facilities in Goa.

Mumbai, July 23, 2014: The Indian pharma company Indoco Remedies has received an approval from the US drug regulator the US Food and Drug Administration (USFDA) for its two manufacturing facilities in Goa. It may be noted here that the US drug regulator has approved the sterile facility and solid dosage facil...

The US based company operated in the area of sterile injectable capacity.

New Delhi, July 16, 2014: The Indian drug firm Sun Pharmaceuticals has acquired Pharmalucence Inc. The US-based company is into sterile injectable capacity and has been acquired by one of the subsidiaries of Sun Pharma.

The investments will be made as part of the expansion plan of Cipla in the UK.

New Delhi, July 8, 2014: Cipla plans to invest up to 100 million pounds in UK over the next few years for launch and development of new drugs as part of its global footprint expansion plans. The company plans to provide high quality affordable medicines to British National Health Service (NHS).

The R&D centres would focus on research in inhalation and complex formulations.

Mumbai, July 6, 2014: The Indian pharma firm Lupin is planning to set up two new R&D centres in the US focusing on research in inhalation and complex formulations.



* Indicates mandatory field.
Please wait while comments are being sent...